Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
76.29
+2.17 (2.93%)
At close: Apr 17, 2026, 4:00 PM EDT
76.10
-0.19 (-0.25%)
After-hours: Apr 17, 2026, 7:00 PM EDT

Veradermics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
21.7753.0816.3
Short-Term Investments
120.1--
Cash & Short-Term Investments
141.8653.0816.3
Cash Growth
167.24%225.75%-
Other Current Assets
10.632.451.27
Total Current Assets
152.4955.5417.56
Net Property, Plant & Equipment
0.13--
Total Assets
152.6255.5417.56
Accounts Payable
2.132.251.85
Accrued Expenses
6.982.471.2
Other Current Liabilities
0.05--
Total Current Liabilities
9.154.723.05
Long-Term Debt
--0.79
Long-Term Leases
0--
Total Long-Term Liabilities
0-0.79
Total Liabilities
9.164.723.84
Common Stock
000
Additional Paid-in Capital
2.350.750.5
Accumulated Other Comprehensive Income
0.06--
Retained Earnings
-123.42-49.23-22.74
Total Common Shareholders' Equity
-121.01-48.48-22.24
Minority Interest
264.4899.335.97
Shareholders' Equity
143.4650.8213.72
Total Liabilities & Equity
152.6255.5417.56
Total Debt
000.79
Net Cash (Debt)
141.8653.0815.51
Net Cash Growth
167.23%242.26%-
Net Cash Per Share
190.4272.0321.05
Book Value
-121.01-48.48-22.24
Book Value Per Share
-162.44-65.79-30.18
Tangible Book Value
-121.01-48.48-22.24
Tangible Book Value Per Share
-162.44-65.79-30.18
Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q